What is the ticker symbol for Apellis Pharmaceuticals, Inc.?

The ticker symbol for Apellis Pharmaceuticals, Inc. is NASDAQ:APLS

Does Apellis Pharmaceuticals, Inc. pay dividends?

No, Apellis Pharmaceuticals, Inc. does not pay dividends

What sector is Apellis Pharmaceuticals, Inc. in?

Apellis Pharmaceuticals, Inc. is in the Healthcare sector

What industry is Apellis Pharmaceuticals, Inc. in?

Apellis Pharmaceuticals, Inc. is in the Biotechnology industry

What country is Apellis Pharmaceuticals, Inc. based in?

Apellis Pharmaceuticals, Inc. is headquartered in United States

When did Apellis Pharmaceuticals, Inc. go public?

Apellis Pharmaceuticals, Inc. initial public offering (IPO) was on November 9, 2017

Is Apellis Pharmaceuticals, Inc. in the S&P 500?

No, Apellis Pharmaceuticals, Inc. is not included in the S&P 500 index

Is Apellis Pharmaceuticals, Inc. in the NASDAQ 100?

No, Apellis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

Is Apellis Pharmaceuticals, Inc. in the Dow Jones?

No, Apellis Pharmaceuticals, Inc. is not included in the Dow Jones index

When was Apellis Pharmaceuticals, Inc. last earnings report?

Apellis Pharmaceuticals, Inc.'s most recent earnings report was on October 30, 2025

When does Apellis Pharmaceuticals, Inc. report earnings?

The next expected earnings date for Apellis Pharmaceuticals, Inc. is February 26, 2026

APLS Stock Financials, Chart, Sentiment & Profile

Profile

Company profile for Apellis Pharmaceuticals, Inc. (APLS)
Metric	Value
Full Name	Apellis Pharmaceuticals, Inc.
Ticker	NASDAQ: APLS
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Nov 9, 2017
Indexes	Not included
Website	apellis.com
Employees	705

Key Metrics

Apellis Pharmaceuticals, Inc. Key Details
Metric	Date	Value
Price	Jan 30, 26	$22.58
Price, 1D Change	Jan 30, 26	-2.04%
	Jan 30, 26	$3B
	Jan 30, 26	-
	Jan 30, 26	76.03
	Jan 30, 26	0.85
	Dec 31, 24	$781M
Revenue, 1Y Change	Dec 31, 24	+97.02%
	Dec 31, 24	-$1.60
EPS, 1Y Change	Dec 31, 24	+64.15%

Events

Apellis Pharmaceuticals, Inc. Events
Metric	Date	Value
Next Earnings	Feb 26, 26
Last Qtr. Earnings	Oct 30, 25
Last Ann. Earnings	Feb 28, 25
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

APLS Estimates
Metric	Date	Value
	Dec 31, 24	-$1.60
EPS Estimate	Feb 26, 26	$0.27
EPS Est. Change	Feb 26, 26	+116.59%
	Dec 31, 24	$781.37M
Revenue Estimate	Feb 26, 26	$1.00B
Revenue Est. Change	Feb 26, 26	+28.58%
Current Price	Jan 30, 26	$22.58
Price Target	-	$28.00
Price Tgt. Change	-	+24.00%

🔒 Log In To Unlock Full Data

EPS

APLS EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2023	-$4.44	-$4.45	-0.32%
2024	-$1.71	-$1.60	+6.88%
2025	$0.27	N/A	+116.59%
2026	-$1.30	N/A	+18.60%

Revenue

APLS revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2023	$392.39M	$396.59M	+1.07%
2024	$766.26M	$781.37M	+1.97%
2025	$1.00B	N/A	+28.58%
2026	$862.73M	N/A	+10.41%

🔒 Log In To Unlock Full Data

Performance

APLS Performance
Metric	Date	Value
Price, 1Y	Jan 30, 26	-25.70%
Price, 3Y	Jan 30, 26	-57.19%
	Jan 30, 26	-24.49%
	Jan 30, 26	-51.10%
	Dec 31, 24	+97.02%
	Dec 31, 24	+1,073.88%
	Dec 31, 24	+64.15%
	Dec 31, 24	+81.94%

🔒 Log In To Unlock Full Data

Technical Indicators

APLS Technical Indicators
Metric	Date	Value
Current Price	Jan 30, 26	$22.58
	Jan 30, 26	$21.98
SMA 200 vs Price	Jan 30, 26	-2.66%
	Jan 30, 26	$23.03
SMA 50 vs Price	Jan 30, 26	+2.00%
	Jan 30, 26	0.85
	Jan 30, 26	$1.30
	Jan 30, 26	48.62
	Jan 30, 26	46.37%
	Jan 30, 26	64.08%

Dividends

APLS Dividends
Metric	Date	Value
	N/A	-
Upcoming	N/A	N/A
	Jan 30, 26	-
	Dec 31, 24	-
	Dec 31, 24	$0.00
	Dec 31, 24	0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

APLS Income & Profitability
Metric	Date	Value
	Dec 31, 24	$781.37M
	Dec 31, 24	-$1.60
	Dec 31, 24	$663.64M
	Dec 31, 24	84.93%
	Dec 31, 24	-$164.98M
	Dec 31, 24	-21.11%
	Dec 31, 24	-$197.88M
	Dec 31, 24	-25.32%
	Dec 31, 24	-$154.53M

🔒 Log In To Unlock Full Data

Financial Health

APLS Financial Health
Metric	Date	Value
	Dec 31, 24	2.06
	Dec 31, 24	4.25
	Dec 31, 24	3.81
	Dec 31, 24	-
	Sep 30, 25	7
	Jan 30, 26	-1.07

Valuations

APLS Valuations
Metric	Date	Value
	Jan 30, 26	76.03
	Jan 30, 26	2.81
	Jan 30, 26	7.12
	Jan 30, 26	34.74
	N/A	-

Balance Sheet

APLS Balance Sheet
Metric	Date	Value
	Dec 31, 24	$228.54M
	Dec 31, 24	$411.29M
	Dec 31, 24	$885.05M
	Dec 31, 24	$788.95M
	Dec 31, 24	$656.51M
	Dec 31, 24	$185.51M
	Dec 31, 24	$469.78M
	Dec 31, 24	$6.75M
	Dec 31, 24	$38.57M

Expenses

APLS Expenses
Metric	Date	Value
	Dec 31, 24	$946.35M
	Dec 31, 24	$828.62M
	Dec 31, 24	$117.72M
	Dec 31, 24	$501.05M
	Dec 31, 24	$1.80M
	Dec 31, 24	$0.00
	Dec 31, 24	$1.16M

Cash Flow

APLS Cash Flow
Metric	Date	Value
	Dec 31, 24	-$87.87M
	Dec 31, 24	-$403.00K
	Dec 31, 24	$149.24M
	Dec 31, 24	$403.00K
	Dec 31, 24	-$88.27M

Recent analyst updates

APLS Recent analyst updates
Metric	Date	Value
William Blair	Oct 16, 24
Scotiabank	Oct 16, 24
Wells Fargo	Sep 24, 24	→
Baird	Sep 23, 24	→
Needham	Sep 20, 24	→
Mizuho	Sep 20, 24	→
JP Morgan	Sep 13, 24	→
JP Morgan	Aug 13, 24	→
Wedbush	Aug 9, 24	→
UBS	Aug 9, 24	→

Analyst sentiment

Institutional ownership

Screeners with APLS

FAQ

What is the ticker symbol for Apellis Pharmaceuticals, Inc.?
The ticker symbol for Apellis Pharmaceuticals, Inc. is NASDAQ:APLS
Does Apellis Pharmaceuticals, Inc. pay dividends?
No, Apellis Pharmaceuticals, Inc. does not pay dividends
What sector is Apellis Pharmaceuticals, Inc. in?
Apellis Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Apellis Pharmaceuticals, Inc. in?
Apellis Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Apellis Pharmaceuticals, Inc. based in?
Apellis Pharmaceuticals, Inc. is headquartered in United States
When did Apellis Pharmaceuticals, Inc. go public?
Apellis Pharmaceuticals, Inc. initial public offering (IPO) was on November 9, 2017
Is Apellis Pharmaceuticals, Inc. in the S&P 500?
No, Apellis Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Apellis Pharmaceuticals, Inc. in the NASDAQ 100?
No, Apellis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Apellis Pharmaceuticals, Inc. in the Dow Jones?
No, Apellis Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Apellis Pharmaceuticals, Inc. last earnings report?
Apellis Pharmaceuticals, Inc.'s most recent earnings report was on October 30, 2025
When does Apellis Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Apellis Pharmaceuticals, Inc. is February 26, 2026

Data Sources & References

APLS Official Website apellis.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1492422/000119312525257374/0001193125-25-257374-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1492422/000095017025029507/0000950170-25-029507-index.htm
APLS Profile on Yahoo Finance finance.yahoo.com/quote/APLS
APLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apls